Artivion, Inc. (AORT)
USD 23.02
(-0.26%)
USD 23.02
(-0.26%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 81.97 Million USD | 10.07% |
| 2022 | 74.47 Million USD | -3.24% |
| 2021 | 76.97 Million USD | 5.38% |
| 2020 | 73.03 Million USD | 37.62% |
| 2019 | 53.07 Million USD | 16.7% |
| 2018 | 45.47 Million USD | -2.58% |
| 2017 | 46.68 Million USD | 77.55% |
| 2016 | 26.29 Million USD | 79.56% |
| 2015 | 14.64 Million USD | 14.95% |
| 2014 | 12.73 Million USD | 30.38% |
| 2013 | 9.77 Million USD | -7.45% |
| 2012 | 10.55 Million USD | 44.22% |
| 2011 | 7.32 Million USD | 13.86% |
| 2010 | 6.42 Million USD | -0.26% |
| 2009 | 6.44 Million USD | -8.92% |
| 2008 | 7.07 Million USD | 26.22% |
| 2007 | 5.6 Million USD | 8.81% |
| 2006 | 5.15 Million USD | 11.8% |
| 2005 | 4.6 Million USD | -3.31% |
| 2004 | 4.76 Million USD | 7.12% |
| 2003 | 4.45 Million USD | -2.94% |
| 2002 | 4.58 Million USD | -26.75% |
| 2001 | 6.25 Million USD | 56.71% |
| 2000 | 3.99 Million USD | -13.12% |
| 1999 | 4.59 Million USD | 35.21% |
| 1998 | 3.4 Million USD | 88.89% |
| 1997 | 1.8 Million USD | 500.0% |
| 1996 | 300 Thousand USD | -25.0% |
| 1995 | 400 Thousand USD | -55.56% |
| 1994 | 900 Thousand USD | -30.77% |
| 1993 | 1.3 Million USD | 333.33% |
| 1992 | 300 Thousand USD | 0.0% |
| 1991 | - USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 81.71 Million USD | -0.32% |
| 2024 Q2 | 80.8 Million USD | -1.12% |
| 2023 Q2 | 78.45 Million USD | 2.86% |
| 2023 FY | 81.97 Million USD | 10.07% |
| 2023 Q4 | 81.97 Million USD | 4.04% |
| 2023 Q3 | 78.79 Million USD | 0.43% |
| 2023 Q1 | 76.27 Million USD | 2.41% |
| 2022 Q4 | 74.47 Million USD | 1.96% |
| 2022 Q2 | 74.31 Million USD | -2.48% |
| 2022 Q3 | 73.04 Million USD | -1.71% |
| 2022 FY | 74.47 Million USD | -3.24% |
| 2022 Q1 | 76.2 Million USD | -0.99% |
| 2021 Q2 | 76.36 Million USD | 4.07% |
| 2021 Q3 | 78.31 Million USD | 2.56% |
| 2021 Q4 | 76.97 Million USD | -1.72% |
| 2021 Q1 | 73.37 Million USD | 0.46% |
| 2021 FY | 76.97 Million USD | 5.38% |
| 2020 Q4 | 73.03 Million USD | 5.24% |
| 2020 Q1 | 54.3 Million USD | 2.32% |
| 2020 Q3 | 69.4 Million USD | 10.67% |
| 2020 Q2 | 62.7 Million USD | 15.48% |
| 2020 FY | 73.03 Million USD | 37.62% |
| 2019 FY | 53.07 Million USD | 16.7% |
| 2019 Q2 | 45.42 Million USD | 2.94% |
| 2019 Q4 | 53.07 Million USD | 9.64% |
| 2019 Q3 | 48.4 Million USD | 6.56% |
| 2019 Q1 | 44.12 Million USD | -2.98% |
| 2018 Q4 | 45.47 Million USD | -1.45% |
| 2018 Q3 | 46.14 Million USD | 0.79% |
| 2018 FY | 45.47 Million USD | -2.58% |
| 2018 Q2 | 45.78 Million USD | 2.69% |
| 2018 Q1 | 44.58 Million USD | -4.49% |
| 2017 Q3 | 27.76 Million USD | 4.62% |
| 2017 Q1 | 25.79 Million USD | -1.89% |
| 2017 Q2 | 26.53 Million USD | 2.88% |
| 2017 FY | 46.68 Million USD | 77.55% |
| 2017 Q4 | 46.68 Million USD | 68.15% |
| 2016 FY | 26.29 Million USD | 79.56% |
| 2016 Q3 | 25.53 Million USD | 0.57% |
| 2016 Q2 | 25.38 Million USD | 0.4% |
| 2016 Q1 | 25.28 Million USD | 72.69% |
| 2016 Q4 | 26.29 Million USD | 2.97% |
| 2015 Q4 | 14.64 Million USD | 1.46% |
| 2015 FY | 14.64 Million USD | 14.95% |
| 2015 Q1 | 13.51 Million USD | 6.08% |
| 2015 Q2 | 13.5 Million USD | -0.04% |
| 2015 Q3 | 14.43 Million USD | 6.84% |
| 2014 Q2 | 12.08 Million USD | 5.22% |
| 2014 Q4 | 12.73 Million USD | -3.21% |
| 2014 FY | 12.73 Million USD | 30.38% |
| 2014 Q3 | 13.16 Million USD | 8.88% |
| 2014 Q1 | 11.48 Million USD | 17.58% |
| 2013 Q2 | 10.84 Million USD | 6.21% |
| 2013 Q3 | 10.2 Million USD | -5.87% |
| 2013 FY | 9.77 Million USD | -7.45% |
| 2013 Q4 | 9.77 Million USD | -4.26% |
| 2013 Q1 | 10.2 Million USD | -3.31% |
| 2012 Q1 | 7.93 Million USD | 8.36% |
| 2012 Q4 | 10.55 Million USD | 3.04% |
| 2012 Q2 | 9.67 Million USD | 21.94% |
| 2012 Q3 | 10.24 Million USD | 5.93% |
| 2012 FY | 10.55 Million USD | 44.22% |
| 2011 Q3 | 6.99 Million USD | 12.46% |
| 2011 FY | 7.32 Million USD | 13.86% |
| 2011 Q4 | 7.32 Million USD | 4.65% |
| 2011 Q2 | 6.22 Million USD | 4.01% |
| 2011 Q1 | 5.98 Million USD | -6.98% |
| 2010 FY | 6.42 Million USD | -0.26% |
| 2010 Q1 | 6.26 Million USD | -2.81% |
| 2010 Q2 | 7.64 Million USD | 22.03% |
| 2010 Q4 | 6.42 Million USD | 2.08% |
| 2010 Q3 | 6.29 Million USD | -17.62% |
| 2009 Q1 | 7.3 Million USD | 3.24% |
| 2009 Q4 | 6.44 Million USD | -0.25% |
| 2009 Q3 | 6.46 Million USD | -2.4% |
| 2009 Q2 | 6.62 Million USD | -9.38% |
| 2009 FY | 6.44 Million USD | -8.92% |
| 2008 Q1 | 5.67 Million USD | 1.28% |
| 2008 Q4 | 7.07 Million USD | 0.27% |
| 2008 FY | 7.07 Million USD | 26.22% |
| 2008 Q3 | 7.05 Million USD | 12.86% |
| 2008 Q2 | 6.25 Million USD | 10.13% |
| 2007 Q4 | 5.6 Million USD | 0.65% |
| 2007 FY | 5.6 Million USD | 8.81% |
| 2007 Q1 | 5.69 Million USD | 10.5% |
| 2007 Q2 | 5.83 Million USD | 2.46% |
| 2007 Q3 | 5.57 Million USD | -4.51% |
| 2006 Q1 | 4.6 Million USD | -0.09% |
| 2006 FY | 5.15 Million USD | 11.8% |
| 2006 Q4 | 5.15 Million USD | 2.79% |
| 2006 Q3 | 5.01 Million USD | 5.25% |
| 2006 Q2 | 4.76 Million USD | 3.43% |
| 2005 Q3 | 4.68 Million USD | 9.89% |
| 2005 Q2 | 4.26 Million USD | -9.52% |
| 2005 Q1 | 4.71 Million USD | -1.07% |
| 2005 FY | 4.6 Million USD | -3.31% |
| 2005 Q4 | 4.6 Million USD | -1.71% |
| 2004 FY | 4.76 Million USD | 7.12% |
| 2004 Q3 | 4.82 Million USD | 5.62% |
| 2004 Q2 | 4.57 Million USD | 9.82% |
| 2004 Q4 | 4.76 Million USD | -1.28% |
| 2004 Q1 | 4.16 Million USD | -6.45% |
| 2003 Q1 | 4.7 Million USD | 2.57% |
| 2003 FY | 4.45 Million USD | -2.94% |
| 2003 Q4 | 4.45 Million USD | -9.83% |
| 2003 Q3 | 4.93 Million USD | 8.82% |
| 2003 Q2 | 4.53 Million USD | -3.57% |
| 2002 Q2 | 7.35 Million USD | 13.39% |
| 2002 Q1 | 6.48 Million USD | 3.59% |
| 2002 Q3 | 4.65 Million USD | -36.63% |
| 2002 FY | 4.58 Million USD | -26.75% |
| 2002 Q4 | 4.58 Million USD | -1.59% |
| 2001 Q4 | 6.25 Million USD | 13.08% |
| 2001 Q2 | 4.91 Million USD | 13.14% |
| 2001 Q3 | 5.53 Million USD | 12.61% |
| 2001 Q1 | 4.34 Million USD | 8.76% |
| 2001 FY | 6.25 Million USD | 56.71% |
| 2000 Q3 | 5.74 Million USD | 12.14% |
| 2000 Q1 | 4.63 Million USD | 0.85% |
| 2000 FY | 3.99 Million USD | -13.12% |
| 2000 Q4 | 3.99 Million USD | -30.5% |
| 2000 Q2 | 5.12 Million USD | 10.55% |
| 1999 Q4 | 4.59 Million USD | -19.35% |
| 1999 Q2 | 4.4 Million USD | 7.32% |
| 1999 Q1 | 4.1 Million USD | 20.59% |
| 1999 FY | 4.59 Million USD | 35.21% |
| 1999 Q3 | 5.7 Million USD | 29.55% |
| 1998 Q3 | 2.7 Million USD | -22.86% |
| 1998 Q2 | 3.5 Million USD | 25.0% |
| 1998 FY | 3.4 Million USD | 88.89% |
| 1998 Q1 | 2.8 Million USD | 55.56% |
| 1998 Q4 | 3.4 Million USD | 25.93% |
| 1997 Q2 | 1.3 Million USD | 18.18% |
| 1997 Q3 | 1.5 Million USD | 15.38% |
| 1997 Q4 | 1.8 Million USD | 20.0% |
| 1997 Q1 | 1.1 Million USD | 266.67% |
| 1997 FY | 1.8 Million USD | 500.0% |
| 1996 Q4 | 300 Thousand USD | -25.0% |
| 1996 Q1 | 300 Thousand USD | -25.0% |
| 1996 FY | 300 Thousand USD | -25.0% |
| 1996 Q2 | 300 Thousand USD | 0.0% |
| 1996 Q3 | 400 Thousand USD | 33.33% |
| 1995 Q3 | 600 Thousand USD | -14.29% |
| 1995 Q4 | 400 Thousand USD | -33.33% |
| 1995 Q2 | 700 Thousand USD | -12.5% |
| 1995 FY | 400 Thousand USD | -55.56% |
| 1995 Q1 | 800 Thousand USD | -11.11% |
| 1994 Q2 | 1.2 Million USD | 0.0% |
| 1994 Q3 | 1 Million USD | -16.67% |
| 1994 Q4 | 900 Thousand USD | -10.0% |
| 1994 FY | 900 Thousand USD | -30.77% |
| 1994 Q1 | 1.2 Million USD | -7.69% |
| 1993 Q2 | 900 Thousand USD | 0.0% |
| 1993 FY | 1.3 Million USD | 333.33% |
| 1993 Q4 | 1.3 Million USD | 18.18% |
| 1993 Q3 | 1.1 Million USD | 22.22% |
| 1992 FY | 300 Thousand USD | 0.0% |
| 1992 Q4 | 300 Thousand USD | 0.0% |
| 1991 FY | - USD | 0.0% |
| 1991 Q4 | - USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Abbott Laboratories | 6.57 Billion USD | 98.752% |
| Allurion Technologies Inc. | 6.17 Million USD | -1228.407% |
| Avanos Medical, Inc. | 163.2 Million USD | 49.77% |
| Butterfly Network, Inc. | 75.83 Million USD | -8.095% |
| Butterfly Network, Inc. | 75.83 Million USD | -8.095% |
| Bio-Rad Laboratories, Inc. | 780.51 Million USD | 89.497% |
| Boston Scientific Corporation | 2.48 Billion USD | 96.7% |
| CONMED Corporation | 318.32 Million USD | 74.248% |
| Edwards Lifesciences Corporation | 1.16 Billion USD | 92.983% |
| Paragon 28, Inc. | 98.06 Million USD | 16.404% |
| Glaukos Corporation | 41.98 Million USD | -95.246% |
| Globus Medical, Inc. | 848.13 Million USD | 90.335% |
| Inspire Medical Systems, Inc. | 33.88 Million USD | -141.924% |
| Integer Holdings Corporation | 239.71 Million USD | 65.803% |
| Medtronic plc | 5.21 Billion USD | 98.429% |
| Myomo, Inc. | 1.8 Million USD | -4445.366% |
| Nevro Corp. | 118.67 Million USD | 30.925% |
| Owlet, Inc. | 6.49 Million USD | -1162.529% |
| Penumbra, Inc. | 388.02 Million USD | 78.873% |
| Vicarious Surgical Inc. | - USD | -Infinity% |
| Smith & Nephew plc | 2.39 Billion USD | 96.577% |
| Sonendo, Inc. | 11.07 Million USD | -640.256% |
| STERIS plc | 674.53 Million USD | 87.847% |
| Stryker Corporation | 4.84 Billion USD | 98.307% |
| Vapotherm, Inc. | 22.96 Million USD | -256.914% |
| Zimmer Biomet Holdings, Inc. | 2.38 Billion USD | 96.563% |